Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now early-phase tilt small index

Head and Neck (HNSCC): early-phase trial registry

1 of 2 indexed Head and Neck (HNSCC) trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #7,188 of 28,707 conditions by registered trial count.

2 US clinical trials · 1 currently recruiting · #7,188 of 28,707 conditions by registered trial count

Head and Neck (HNSCC): 2 US clinical trials tracked, 1 recruiting.

Head and Neck (HNSCC) is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Boundless Bio, running 1 of these trials.

Enrollment posture brief

Registry condition head-and-neck-hnscc

OPEN 1 | RECR 50% | LATE 0 | EARLY 2 | RANK #7188 | SPON 1

Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Head and Neck (this)50%
Open-enrollment share among volume-matched conditions near Head and Neck (HNSCC)

Head and Neck (HNSCC) lists 1 open slots (50% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Head and Neck (HNSCC) on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Head and Neck (HNSCC) is recruiting above its size-band peers.

    1 of 2 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 12

Phase Distribution

PhaseTrial count
Phase 1 2

Top Sponsors

Boundless Bio 1 trials

Named interventions

Most-linked intervention names on Head and Neck (HNSCC) records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

BBI-825 Drug
1 trials
BBI-355 Drug
1 trials
Erlotinib Drug
1 trials
CP-383 Drug
1 trials
Futibatinib Drug
1 trials

US sites by state

Facility locations filed on Head and Neck (HNSCC) trials. A trial with sites in several states counts in each.

Virginia 2 trials
Texas 2 trials
Michigan 2 trials
Florida 2 trials
Colorado 2 trials
Wisconsin 1 trials
Washington 1 trials
Utah 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Head and Neck (HNSCC) page

2 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 1 Head and Neck (HNSCC) trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Boundless Bio sponsors the most Head and Neck (HNSCC) trials on record, review their full trial history before evaluating a specific study. See Boundless Bio's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Head and Neck (HNSCC) condition card totals 2 registered trials; most-linked intervention BBI-825; top US site state Virginia. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.